Active Cancer Biomarkers Grants

PI Name Organization - Company Titlesort descending Major Program / Research Group FOA
Mehta, Anand S Medical University Of South Carolina Glycopathology of HCC: identification of the source cells of serum fucosylation Alliance of Glycobiologists for Cancer Research PAR-17-206: Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories
Zhang, Hui Johns Hopkins University Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer Early Detection Research Network, EDRN Biomarker Development Lab RFA-CA-14-014: The Early Detection Research Network: Biomarker Developmental Laboratories
Pitteri, Sharon Stanford University Glycosylation and Immune Evasion in Urologic Tumors Alliance of Glycobiologists for Cancer Research PAR-17-206: Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories
Bresalier, Robert S University Of Tx Md Anderson Can Ctr Great Lakes New England Clinical Validation Center Early Detection Research Network, EDRN Clinical Validation Center RFA-CA-21-033: The Early Detection Research Network: Clinical Validation Centers
Hecht, Stephen S University Of Minnesota High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck PA-20-185: NIH Research Project Grant
Mantis, Nicholas J. Wadsworth Center High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology COVID Serology RFA-CA-20-039: Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences
Vizio, Dolores Di Cedars-Sinai Medical Center High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer PAR-16-276: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
Vigneron, Daniel B University Of California, San Francisco Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients Consortium for Imaging and Biomarkers PAR-16-089: Imaging and Biomarkers for Early Cancer Detection
Putluri, Nagireddy Baylor College Of Medicine Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers PAR-15-308: Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention
Liu, Yang University Of Pittsburgh At Pittsburgh Imaging nanoscale chromatin folding in early carcinogenesis PA-19-056: Research Project Grant
Fan, Rong Yale University Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies COVID Serology RFA-CA-20-039: Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences
Cooperberg, Matthew R University Of California, San Francisco Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment PA-13-302: Research Project Grant
Li, Wenyuan University Of California Los Angeles Informatics resources for liquid biopsy research PAR-15-332: Early-Stage Development of Informatics Technologies for Cancer Research and Management
Nappi, Lucia Provincial Health Services Authority Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Stowell, Sean R Brigham And Women'S Hospital Integrating microbial glycan arrays with genomic sequences to study host microbe interactions RFA-RM-18-036: Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions

Pages